A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
showcase AI’s potential to accelerate drug development Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the ...
WVU has formed a strategic partnership with GATC Health Corp, a tech-bio company that uses artificial intelligence to ...
Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...
The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...
Bourla said the experts were helping Pfizer "make better and more sound decisions," and the company could start a late-stage ... development of a twice-daily version of the drug in late 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results